- Abbott (NYSE: ABT) to acquire Exact Sciences (NASD: EXAS) in $21 Billion All-Cash Deal to Expand Global Cancer Screening and Precision Oncology Diagnostics Portfolio The deal will make Exact Sciences a subsidiary, helping Abbott reach $12 billion in diagnostics sales. Exact’s Madison, Wisconsin presence and leadership will remain, with the CEO advising during transition. Shareholder and regulatory approvals are expected before closing in mid-2026. (Link)
- Merck (NYSE: MRK) to acquire Cidara Therapeutics (NASD: CDTX) for $9.2 Billion, Gaining Late-Phase Antiviral CD388 for Influenza Prevention After the deal’s approval, Cidara Therapeutics will strengthen Merck’s presence in antivirals with CD388 targeting high-risk influenza populations. The acquisition structure ensures all Cidara shares are purchased, pending regulatory clearance, with closing planned for the first quarter of 2026. (Link)
- GE Healthcare (NASD: GEHC) to acquire Intelerad in $2.3 Billion Deal to Expand Cloud-Enabled and AI-Driven Imaging Platform for Radiology, Cardiology, and Outpatient Enterprise Markets The integration will modernize imaging workflows for outpatient and ambulatory care, leveraging Intelerad’s SaaS and AI strengths to streamline operations, unify data, and improve provider efficiency. Backed by global reach and financial flexibility, GE HealthCare expects significant recurring revenue and top-line growth from expanded cloud imaging offerings. (Link)
- Solventum (NYSE: SOLV) to acquire Acera Surgical for $725 Million Plus Milestone Payments, Expanding Advanced Wound Care Portfolio with Synthetic Tissue Matrices Technology Acera’s Restrata product, a fully resorbable electrospun fiber matrix, treats hard-to-heal acute care wounds by supporting cellular growth and healing. Solventum will use its sales expertise and international presence to accelerate Restrata’s adoption, aiming for commercial and operational synergies that drive leadership in advanced regenerative wound care. (Link)
- Halozyme Therapeutics (NASD: HALO) completes $750 Million Acquisition of Elektrofi, Unlocks Hypercon™ Technology for High-Concentration Biologics and Expands Drug Delivery Offerings Hypercon™ enables highly concentrated biologics to be delivered subcutaneously, improving patient convenience and supporting at-home care. Halozyme Therapeutics will pursue royalty-based licensing for products built on Elektrofi’s technology, with expected milestone payments and clinical launches that could begin driving revenues and broader market impact starting in 2030. (Link)
- Nanox Imaging (NASD: NNOX) to acquire VasoHealthcare IT from Vaso Corporation (OTCQX: VASO) for Up to $800,000 to Accelerate U.S. Rollout of FDA-Cleared AI Medical Imaging Solutions Nanox’s platform brings real-time AI analysis and automated detection to routine CT imaging, offering multiple FDA-cleared solutions for radiology and cardiology. The acquisition leverages VasoHealthcare IT’s healthcare relationships for broader market coverage, enabling faster hospital adoption and improved integration of AI-driven workflows for earlier chronic disease identification. (Link)
- RadNet (NASD: RDNT) acquires River Radiology, Strengthening New York Imaging Network and Expanding Lenox Hill Radiology’s Geographic Reach River Radiology’s Kingston facility delivers patient-centered care with advanced imaging services such as MRI, CT, PET/CT, 3D mammography, and ultrasound. Extended weekday hours and flexible scheduling support provider referrals. Its reputation for accurate reports, innovative screening, and compassionate service has defined medical imaging excellence across the Hudson Valley region. (Link)
- ClearPoint Neuro (NASD: CLPT) completes acquisition of IRRAS, Bringing IRRAflow System and Expanding Neurocritical Care and Drug Delivery Capabilities IRRAflow uses active irrigation and drainage to effectively treat brain haemorrhages, leading to faster clearance of blood, fewer catheter infections, and reduced risk of blockages compared to passive drains. Clinical studies report improved patient outcomes, shorter treatment duration, and lower hospital costs for those treated with this innovative technology. (Link)
- Reliant Healthcare and Care Fusion Rx Merge to Transform U.S. Infusion Therapy with Expanded Home and Ambulatory Service Platform Reliant Healthcare operates 14 infusion centers and specialty pharmacies across the southern U.S., while Care Fusion Rx brings expertise in advanced therapies—including immunoglobulin treatments—for chronic and rare diseases. The merger will drive national expansion with new locations, broader coverage, and investment in patient-focused care guided by experienced leadership. (Link)
- ARC Health Partners acquires Clarity Counselling Center, Adding Wilmington-Based Practice to 23-Group National Network and Expanding North Carolina Reach with Backing from Thurston Group Clarity Counselling Center offers therapy for individuals, couples, and families, specializing in anxiety, depression, trauma, ADHD, grief, and relationship issues in Wilmington, NC. Their team of over 13 therapists uses evidence-based therapies like CBT and DBT, ensuring client-therapist matching and personalized care for children, teens, and adults. (Link)
- MRO acquires Clinetic, via its financial sponsors Healthworx and Parthenon Capital Partners to Transform Patient Recruitment and Streamline Clinical Trial Enrollment with Scalable AI-EHR Integration Clinetic’s software uses AI to analyse both structured and unstructured patient data for real-time matching to clinical studies, dramatically accelerating recruitment. By integrating with EHRs, it supports secure workflow automation, precise cohort building, and reduces site workload—expediting enrollment for a nationwide hospital network and the Q-Centrix Research Network. (Link)
- OhioHealth, a Columbus-based nonprofit health system, is acquiring the independent 220-bed Fairfield Medical Center in Lancaster, OH. The deal will expand OhioHealth’s network to 17 hospitals and enhance regional care. The boards endorsed the merger in September 2024 after a non-binding letter of intent, with benefits including increased efficiencies, improved quality measures, and access to larger system resources for a growing population. Pending regulatory approvals and government filings, the deal is expected to close in 2026; no financial terms were disclosed. (Link)
- WVU Health System to acquire Independence Health System, Growing to 30-Hospital Network with $800 Million Investment Commitment Morgantown-based WVU Health System will acquire Greensburg’s Independence Health System, including five hospitals, physician groups, and subsidiaries, rebranding under WVU Medicine. WVU pledges $800 million over five years for facility modernization. Closing anticipated in fall 2026. (Link)
- Function Health raises $298 Million Series B led by Redpoint Ventures and a16z at $2.5 Billion valuation for Medical Intelligence Lab launch. Function Health offers comprehensive lab testing, body scans, and health data consolidation to detect over 1,000 conditions early via more than 100 biomarkers. The funding will expand U.S. locations, develop AI health features, and lower annual membership pricing. It also backs the Medical Intelligence Lab to advance health and longevity research for proactive care. (Link)
News Healthcare Deals, Investments & Update Week ending Nov 10th 2025
1. BillionToOne (NASD: BLLN) raises $273 Million in U.S. IPO Led by J.P. Morgan, Piper Sandler, Jefferies, and William Blair
The firm’s technology powers advanced prenatal and oncology diagnostics through its Unity and Northstar tests. Analysts view its IPO success as reflecting growing investor confidence in biotech innovation despite wider market uncertainty. The offering signals renewed momentum in healthcare listings, inspired by other major sector filings such as Medline’s. (Link)
2. Sonida Senior Living (NYSE: SNDA) and CNL Healthcare Properties announce $1.8 Billion Merger Creating the Nation’s Eighth Largest Senior Housing Owner
The merger focuses on expanding nationwide senior living operations with an emphasis on quality care and operational integrity. Both companies aim to strengthen their market position through shared values and strategic growth in key U.S. regions, while investors anticipate improved financial performance and stronger long-term value within the senior housing sector. (Link)
3. QOL Medical to acquire Evoke Pharma (NYSE: EVOK) in All-Cash Deal Worth $11 Per Share
The agreement merges complementary strengths in gastrointestinal innovation, expanding access to advanced treatments for diabetic gastroparesis. Both companies underscored the transaction’s strategic value in broadening therapeutic offerings and commercial reach. Supported by cash reserves, the acquisition awaits regulatory and shareholder approval, marking a step toward enhanced capabilities in GI-focused patient care. (Link)
4. Organon sells Jada System to Laborie Medical Technologies in $465 Million Deal
The transaction supports reorganization and debt reduction, positioning both companies for strategic growth. Laborie will expand its maternal health portfolio by incorporating the Jada device and its specialized workforce. Organon aims to redirect focus toward women’s health biopharma opportunities after recent leadership transitions, declining sales, and halted drug development initiatives. (Link)
5. Lifecare Home Health acquires Infinity Hospice Care, via its financial sponsor Zenyth Partners, expands Hospice Services Across Nevada and Arizona
The collaboration enhances post-acute care delivery through unified expertise in compassionate and high-acuity hospice services. Combining national infrastructure with community-based operations, both organizations aim to elevate patient experiences centered on dignity and care quality. Leadership underscores innovation and continuity as key drivers in expanding coordinated healthcare across multiple states. (Link)
6. Optain Health acquires EyePACS to Advance AI-Driven Retinal Screening and Oculomics Innovation
The collaboration enhances early disease detection through advanced AI imaging, expanding access to preventive care and population health programs. EyePACS’s nationwide network will integrate Optain’s automation and multilingual capabilities, improving clinical efficiency and diagnostic scalability while advancing oculomics research aimed at identifying systemic diseases through non-invasive retinal analysis. (Link)
7. JLL Partners combines Vascular Technology Incorporated and Parks Medical Electronics to Build Vascular and Robotics Device Platform
The merger unites advanced capabilities in vascular diagnostics and Doppler ultrasound technologies to enhance precision and clinical performance. By combining innovation with U.S.-based production, the partnership focuses on improving device reliability and expanding access to next-generation vascular tools that support surgical, therapeutic, and diagnostic applications worldwide. (Link)
8. Omega Systems acquires PEAKE Technology Partners, via its financial sponsor Revelstoke Capital Partners to strengthen Healthcare Managed IT and Cybersecurity Capabilities
The acquisition enhances healthcare IT services through advanced data security, compliance, and AI-driven clinical capabilities. By integrating expertise in electronic health records and HIPAA management, the partnership aims to boost operational performance and patient outcomes while expanding regional reach and reinforcing leadership in secure, technology-driven healthcare infrastructure nationwide. (Link)
9. Acumed acquires TECHFIT Digital Surgery Assets to Advance Patient-Tailored Craniomaxillofacial Solutions
The integration brings advanced digital planning and reconstruction capabilities to improve precision in surgical procedures across multiple specialties. By expanding personalized, data-driven care, the company aims to advance innovation in reconstructive and orthopaedic solutions. Leadership additions and global strategy alignment will support broader adoption of patient-tailored surgical technologies worldwide. (Link)
10. RadNet and DeepHealth acquire Alpha RT to Expand Remote MRI Scanning and AI Safety Capabilities
The integration enhances imaging efficiency through AI-powered monitoring, advanced training, and resource optimization to tackle technologist shortages. By combining intelligent staffing with remote imaging technology, the partnership strengthens scalability and nationwide support. It aligns with continued investments in AI-driven diagnostics, expanding capabilities across multiple medical imaging modalities and platforms. (Link)